Three N.C. companies pitch investors at Mid-Atlantic Bio
Diabetes-related treatments and a drug-discovery platform were among the dozen up-and-coming technologies presented at Mid-Atlantic Bio on Thursday. The first session, dubbed a first look, gave companies five minutes to present what was unique about their technologies. The vision, if presented correctly, would be a bit of a tease, designed to fill the company exec’s calendar with meeting requests from investors or potential partners. The three North Carolina pitches: Katharos Al Bender held up the company’s product – a tube containing a matrix of material. If you add this to a standard dialysis setup, the phosphorous levels in a...
Read More
